Delivery Order SPE2DB22D3301-SPE2DB25FZ1CJ
Award Date 9/17/25
Potential Completion Date 10/8/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,499.34 to AmerisourceBergen Drug Corp for 60 tablets of Lynparza 150 mg, a specialty pharmaceutical product used in oncology treatment. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with fulfillment to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,543.70 by the Defense Logistics Agency on September 11, 2025, with completion expected by October 2, 2025. The contract calls for the supply of Lynparza 100 mg tablets in quantities of 60 units, a targeted oncology medication used in cancer treatment. The award was made on a firm fixed-price basis without set-aside designation, indicating...
- The Defense Logistics Agency awarded a delivery order valued at $10,519.62 to AmerisourceBergen Drug Corp for 120 tablets of Lynparza 100 mg on August 20, 2025, with an ultimate completion date of September 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child order, this delivery falls under a larger contract...
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a $9,755.67 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide 120 tablets of the cancer drug Lynparza (Olaparib) 150mg. The place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania, and the period of performance is from August 31, 2023 through September 22, 2023. No subcontractors or set aside designations were indicated. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of LYNPARZA 150 mg tablets (60-count unit dose) with a ceiling value of $10,499.34. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $52,598.10 for the supply of Lynparza 100 mg tablets (120-count units) on September 4, 2025, with an ultimate completion date of September 25, 2025. The contract carries no set-aside designation and was competitively awarded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical procurement for military and federal healthcare systems. The place of performance is...
- The Defense Logistics Agency awarded a $42,270.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lynparza 150 mg tablets (120-count units) on August 12, 2025, with an ultimate completion date of September 3, 2025. This non-competitive delivery order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,519.62 for 120 tablets of Lynparza 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside transaction executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lynparza 150 mg tablets (120 count) with a contract value of $10,567.60. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 2, 2025. This delivery order...
- This delivery order, awarded August 26, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 120 tablets of Lynparza 100 mg at a ceiling value of $10,519.62. The award is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 17, 2025. This delivery order is a child...